{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:33:58Z","timestamp":1782826438716,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vascn.2019.106649","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T02:48:02Z","timestamp":1573526882000},"page":"106649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty"],"prefix":"10.1016","volume":"101","author":[{"given":"Ashraf","family":"Mina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vascn.2019.106649_bb0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/clinchem\/41.1.92","article-title":"Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening","volume":"41","author":"Armbruster","year":"1995","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.vascn.2019.106649_bb0010","series-title":"Uncertainty of measurement (inter-batch\/lot precision)","author":"Limited ASoCIaA","year":"2005"},{"issue":"5","key":"10.1016\/j.vascn.2019.106649_bb0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/dta.1641","article-title":"Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse","volume":"6","author":"Beck","year":"2014","journal-title":"Drug Testing and Analysis"},{"issue":"1","key":"10.1016\/j.vascn.2019.106649_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/FTD.0000000000000475","article-title":"Lack of detection of new amphetamine-like drugs using conventional urinary immunoassays","volume":"40","author":"Begeman","year":"2018","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.vascn.2019.106649_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S88935","article-title":"Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: Influence of dose and metabolites of opioids","volume":"6","author":"Berg","year":"2015","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"9","key":"10.1016\/j.vascn.2019.106649_bb0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jat\/bkt063","article-title":"Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: Results of a national proficiency test","volume":"37","author":"Bertol","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"issue":"1","key":"10.1016\/j.vascn.2019.106649_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/clinchem\/39.1.104","article-title":"Analytical performance evaluation of EMIT II monoclonal amphetamine\/methamphetamine assay: More specificity than EMIT d.a.u. monoclonal amphetamine\/methamphetamine assay","volume":"39","author":"Dasgupta","year":"1993","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.vascn.2019.106649_bb0040","series-title":"One source-multiple technologies","author":"Fisher","year":"2012"},{"issue":"9","key":"10.1016\/j.vascn.2019.106649_bb0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1515\/cclm-2016-0831","article-title":"Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency","volume":"55","author":"Franz","year":"2017","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"1","key":"10.1016\/j.vascn.2019.106649_bb0050","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1016\/S0003-2670(97)00608-9","article-title":"Strengths and limitations of immunoassays for effective and efficient use for pesticide analysis in water samples: A review","volume":"362","author":"Henniona","year":"1998","journal-title":"Analytica Chimica Acta"},{"issue":"2\u20133","key":"10.1016\/j.vascn.2019.106649_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0379-0738(02)00430-9","article-title":"Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood","volume":"131","author":"Hino","year":"2003","journal-title":"Forensic Science International"},{"issue":"7","key":"10.1016\/j.vascn.2019.106649_bb0060","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jat\/27.7.471","article-title":"Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens","volume":"27","author":"Hsu","year":"2003","journal-title":"Journal of Analytical Toxicology"},{"issue":"1","key":"10.1016\/j.vascn.2019.106649_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22021","article-title":"Evaluation of CEDIA and DRI drugs of abuse immunoassays for urine screening on a thermo Indiko plus analyzer","volume":"31","author":"Kohler","year":"2017","journal-title":"Journal of Clinical Laboratory Analysis"},{"issue":"3","key":"10.1016\/j.vascn.2019.106649_bb0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0004563217725089","article-title":"False-negative results in the immunoassay analysis of drugs of abuse: Can adulterants be detected by sample check test?","volume":"55","author":"Matriciani","year":"2018","journal-title":"Annals of Clinical Biochemistry"},{"issue":"2","key":"10.1016\/j.vascn.2019.106649_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/15563650.2013.768344","article-title":"Cross-reactivity studies and predictive modeling of \"Bath Salts\" and other amphetamine-type stimulants with amphetamine screening immunoassays","volume":"51","author":"Petrie","year":"2013","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"issue":"4","key":"10.1016\/j.vascn.2019.106649_bb0080","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays","volume":"9","author":"Pettersson Bergstrand","year":"2017","journal-title":"Drug Testing and Analysis"},{"issue":"2","key":"10.1016\/j.vascn.2019.106649_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/jat\/bku133","article-title":"Determination of designer drug cross-reactivity on five commercial immunoassay screening kits","volume":"39","author":"Regester","year":"2015","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.vascn.2019.106649_bb0090","series-title":"Examination of urine in clinical chemistry: Theory, analysis and correlation","author":"Schumann","year":"1989"},{"issue":"7","key":"10.1016\/j.vascn.2019.106649_bb0095","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jat\/26.7.519","article-title":"Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples","volume":"26","author":"Wiegand","year":"2002","journal-title":"Journal of Analytical Toxicology"},{"issue":"4","key":"10.1016\/j.vascn.2019.106649_bb0100","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1520\/JFS13836J","article-title":"CEDIA for screening drugs of abuse in urine and the effect of adulterants","volume":"40","author":"Wu","year":"1995","journal-title":"Journal of Forensic Sciences"},{"issue":"4","key":"10.1016\/j.vascn.2019.106649_bb0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jat\/25.4.258","article-title":"Profiles of urine samples taken from Ecstasy users at rave parties: Analysis by immunoassays, HPLC, and GC-MS","volume":"25","author":"Zhao","year":"2001","journal-title":"Journal of Analytical Toxicology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871919304071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871919304071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:03:49Z","timestamp":1761005029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871919304071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":21,"alternative-id":["S1056871919304071"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2019.106649","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2019.106649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106649"}}